Literature DB >> 18751384

HOXB2, an adverse prognostic indicator for stage I lung adenocarcinomas, promotes invasion by transcriptional regulation of metastasis-related genes in HOP-62 non-small cell lung cancer cells.

Kentaro Inamura1, Yuki Togashi, Hironori Ninomiya, Takashi Shimoji, Tetsuo Noda, Yuichi Ishikawa.   

Abstract

BACKGROUND: Previously, using microarray and real-time RT-PCR analysis, we established that HOXB2 is an adverse prognostic indicator for Stage I lung adenocarcinomas. HOXB2 is one of the homeobox master development-controlling genes regulating morphogenesis and cell differentiation.
MATERIALS AND METHODS: The molecular functions of HOXB2 were analyzed with a small interfering RNA (siRNA) approach in HOP-62 human non-small cell lung cancer (NSCLC) cells featuring high HOXB2 expression. Matrigel invasion assays and microarray gene expression analysis were compared between the HOXB2-siRNA cells and the control cells.
RESULTS: The Matrigel invasion assays showed attenuation of HOXB2 expression by siRNA to result in a significant decrease of invasiveness compared to the control cells (p = 0.0013, paired t-test). On microarray gene expression analysis, up-regulation of many metastasis-related genes and others correlating with HOXB2 expression was observed in the control case. With attenuation of HOXB2 expression, downregulation was noted for laminins alpha 4 and 5, involved in enriched signaling, and for Mac-2BP (Mac-2 binding protein) and integrin beta 4 amongst the genes having an enriched glycoprotein ontology.
CONCLUSION: HOXB2 promotes invasion of lung cancer cells through the regulation of metastasis-related genes.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18751384

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  10 in total

1.  Circular RNA 0001785 regulates the pathogenesis of osteosarcoma as a ceRNA by sponging miR-1200 to upregulate HOXB2.

Authors:  Shenglong Li; Yi Pei; Wei Wang; Fei Liu; Ke Zheng; Xiaojing Zhang
Journal:  Cell Cycle       Date:  2019-05-22       Impact factor: 4.534

2.  Transcription factor HOXB2 upregulates NUSAP1 to promote the proliferation, invasion and migration of nephroblastoma cells via the PI3K/Akt signaling pathway.

Authors:  Bo Luo; Shasha Feng; Tianliang Li; Jun Wang; Zhaoyang Qi; Yi Zhao; Bo Hu
Journal:  Mol Med Rep       Date:  2022-04-29       Impact factor: 3.423

3.  High expression of homeobox B2 predicts poor survival of colon adenocarcinoma by enhancing tumor proliferation and invasion.

Authors:  Shengjie Li; Yujie Wang; Zhiqiang Xuan; Yue Zhang; Zhongxing Miao
Journal:  Ir J Med Sci       Date:  2022-03-23       Impact factor: 1.568

4.  TINAGL1 and B3GALNT1 are potential therapy target genes to suppress metastasis in non-small cell lung cancer.

Authors:  Hideaki Umeyama; Mitsuo Iwadate; Y-h Taguchi
Journal:  BMC Genomics       Date:  2014-12-08       Impact factor: 3.969

5.  LNRRIL6, a novel long noncoding RNA, protects colorectal cancer cells by activating the IL-6-STAT3 pathway.

Authors:  Jiaxing Wang; Junfeng Zhou; Caiyun Jiang; Jing Zheng; Hiroki Namba; Pan Chi; Tetsuya Asakawa
Journal:  Mol Oncol       Date:  2019-09-30       Impact factor: 6.603

6.  miR‑139‑5p enhances cisplatin sensitivity in non‑small cell lung cancer cells by inhibiting cell proliferation and promoting apoptosis via the targeting of Homeobox protein Hox‑B2.

Authors:  Hailian Du; Ya'nan Bao; Chunying Liu; Anqiao Zhong; Yikai Niu; Xingping Tang
Journal:  Mol Med Rep       Date:  2020-12-10       Impact factor: 2.952

7.  Construction and validation of a risk prediction model for clinical axillary lymph node metastasis in T1-2 breast cancer.

Authors:  Na Luo; Ying Wen; Jingfen Ji; Wenjun Yi; Qiongyan Zou; Dengjie Ouyang; Qitong Chen; Liyun Zeng; Hongye He; Munawar Anwar; Limeng Qu
Journal:  Sci Rep       Date:  2022-01-13       Impact factor: 4.379

8.  HOXB2 increases the proliferation and invasiveness of colon cancer cells through the upregulation of CCT6A.

Authors:  Xuelian Yang; Yuanhe Tong; Wenxia Ye; Lifen Chen
Journal:  Mol Med Rep       Date:  2022-03-22       Impact factor: 2.952

9.  A methylation-driven gene panel predicts survival in patients with colon cancer.

Authors:  Yaojun Peng; Jing Zhao; Fan Yin; Gaowa Sharen; Qiyan Wu; Qi Chen; Xiaoxuan Sun; Juan Yang; Huan Wang; Dong Zhang
Journal:  FEBS Open Bio       Date:  2021-07-28       Impact factor: 2.693

10.  CMS: a web-based system for visualization and analysis of genome-wide methylation data of human cancers.

Authors:  Fei Gu; Mark S Doderer; Yi-Wen Huang; Juan C Roa; Paul J Goodfellow; E Lynette Kizer; Tim H M Huang; Yidong Chen
Journal:  PLoS One       Date:  2013-04-22       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.